The recent FDA approval of automated, matched PSA and free PSA (fPSA) tests marks an important step in the fight against prostate cancer. The new automated, random-access Hybritech tests for use on the Beckman Coulter Access Immunoassay System pro
Read More
Men with biomarker HSD3B1 may exhibit resistance to combined radiation and hormone therapy for prostate cancer.
Read More
Sylvester Comprehensive Cancer Center’s Game Changer vehicles are offering PSA screening for prostate cancer.
Read More
In a large study, more men received a prostate-specific antigen or PSA test to detect prostate cancer following revisions by the USPSTF on screening.
Read More
Researchers believe that men with Lynch syndrome could benefit from regular PSA testing from age 40 to detect early signs of prostate cancer.
Read More